The Bengal Bite 🐯 | November Digest 2020
Last Month's Newsletters and Most Read Articles:
Rising Tide of Legalization | November 6 Forbes | The Future Of Marijuana Under Biden and a GOP Senate: Kris Krane gives his overview on what is next for legal cannabis. As votes continue to be tallied, questions of how final election results will affect the cannabis industry remain. On balance, the lack of unified Democratic control may hinder many major reforms, but opportunities remain including passage of the SAFE Banking Act. While some results are still in question, one thing is clear from Election Night - all cannabis ballot measures passed by historic margins. American voters of all parties overwhelmingly support cannabis legalization.
Partners in the News | November 13 New Cannabis Ventures | Institutional Investor Buys $79 Million of Green Thumb Industries Stock: On October 30th, Green Thumb Industries disclosed the sale of approximately $79 million of subordinated voting shares. The sale demonstrated institutional appetite for industry as shares were sold to a single, undisclosed institutional buyer with the stock price near a 52-week high.
The Science of Cannabis | November 20 Mashable | Sleep and CBN: What we really know about the buzzy cannabis compound: The cannabinoid CBN has shown promise in helping cannabis consumers sleep. Due to increased consumer demand and industry experimentation, we are beginning to learn more about the sedative qualities of CBN. Turns out that CBN works, but it has to be in combination with CBD. Bloom Farms’ Sleep Tincture, featured in Mashable, contains a 5:1 CBD:CBN ratio.